Bayer has introduced a new microchip scanner which is capable of reading all chips, including encrypted ones.
The company says the new Tracer Advance Isomax V scanner offers exceptional reading distances of more than twice those of other scanners on the market, making it a very versatile tool ideally suited for use in companion animal practices or for detecting microchips in larger animals such as horses.
The technology that gives this scanner its backward compatibility with non ISO standard chips means practices can now save money by only having to buy one scanner, whereas previously two were required to be able to read all types of chip.
Other features of the device include digital signal processing (DSP), which protects against radio interference from TVs and PCs, and connectivity via USB, RS232 or optional Bluetooth interface.
The Tracer Advance Isomax V scanner is available from Bayer and is priced at £499.95. It comes with a 30-month warranty. Contact your Bayer territory representative for further details.
The RCVS and the Veterinary Medicines Directorate (VMD) will be holding a free Masterclass offering practical guidance on the requirements of the Veterinary Practice Premises Register, on Saturday 4 April, at BSAVA Congress.
If you are concerned about medicines inspections and would like further information about complying, this is your chance to find out what you need to do.
By 1 April, all practice premises from which medicines are supplied should be registered with the RCVS. All such premises are then subject to inspection - by either Practice Standards Scheme inspectors, if accredited under the Scheme, or VMD inspectors. Will you be ready if an inspector calls?
Suitable for veterinary surgeons, veterinary nurses and practice managers, the interactive session will be held from 10am - 12noon, with presentations from VMD and the Chief Inspector of the Practice Standards Scheme, followed by group discussion and plenty of time for questions and answers.
Attendance at the Masterclass, which will be held in Hall 6 of the ICC in Birmingham, is free to BSAVA passholders.
For your free ticket, contact Fiona Harcourt on 020 7202 0773, f.harcourt@rcvs.org.uk, or during Congress visit the RCVS Stand, number 918, opposite the catering stand in the Exhibition hall.
A new long acting sheep injection has been launched by Fort Dodge Animal Health which the company says will offer significant benefits to sheep farmers for both internal and external parasite control.
Cydectin 2% LA for sheep is the latest product to join the Cydectin range and follows the long acting injection for cattle.
Based on Moxidectin, the product delivers a long action against worms, up to 111 days and scab, 60 days from a single injection.
Andrew Wylie from Fort Dodge said: "To put this into context, apart from the existing Cydectin range which lasts up to 35 days, no other product is licensed with persistent activity against worms and scab. Cydectin 2% LA for sheep offers three times the worm cover and double the scab cover from a single injection.
"Therefore farmers will benefit from Cydectin 2% LA through the combination of a single injection with extended persistency leading to a reduction in the number of treatments needed for worms and scab and the potential increase in lamb weight gain due to a lower worm and scab challenge."
Fort Dodge recommends the following three key uses for Cydectin 2% LA given the persistent effect and single shot:
Administration is by a single sub-cutaneous injection high up the neck at the base of the ear which is designed to limit the withhold period to 104 days. The technique is not difficult and, if used with the multidose applicator supplied, farmers will find it a straightforward procedure.
Cydectin 2% LA is available in 50ml, 200ml and 500ml bottles and with a dose rate of 1ml per 20kg, a 500ml pack will treat 200 sheep at 50kg. For further, call Fort Dodge on 01489 781711.
According to the results of DairyCheck 2008, Intervet/Schering-Plough Animal Health's subsidised milk testing service, 65% of herds tested positive for IBR infection, 69% positive for Leptospirosis and the majority of herds tested showed evidence of previous BVD exposure.
According to Intervet/Schering Plough, it is widely known that exposure levels of these three endemic diseases are high, yet many producers don't see the hidden losses. Making use of DairyCheck can demonstrate infection levels on an individual unit and help encourage a control and management programme to be put in place
Vet adviser Ruth Vernon said: "It can be a case of 'out of sight, out of mind'. After the initial infection, cows may appear healthy, but be suffering from the effects of immune suppression as a result of BVD virus infection. This results in herd performance that is often below expected levels."
"When the news is good - and on average around 33% of DairyCheck tested herds were found to be clear of all three diseases - farmers need guidance and advice on keeping a naïve herd clear of disease.
"Taking time to explain how to incorporate biosecurity measures on a day-to-day basis as well as quarantine and vaccination programmes can significantly improve the health status of previously infected units."
Further information on DairyCheck is available from Intervet/Schering-Plough Account Managers.
Janssen Animal Health has launched a range of skincare products - Cavalesse® and Cavalesse® Topical - to help maintain and support a healthy skin in horses prone to summer skin allergies.
According to the company, summer skin allergies, including sweet itch, which is caused by reactions to bites from Culicoides midges, can be serious and frustrating conditions that affect three to five per cent of all horses in the UK. These allergies can be difficult to manage and are often a real challenge for both horse owners and vets alike.
Cavalesse is a natural food supplement containing a specialised formulation of water-soluble vitamins and minerals, including Nicotinamide. Once a month the contents of each sachet are dissolved in water to form an oral solution, which can be administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat such as a sugar lump. The supplement helps horses maintain a healthy skin by reducing histamine release within the skin, moderating the excessive immune response within the skin, reducing anti-inflammatory reactions and suppressing antigen induced transformation.
To complete the Cavalesse skin management range, Cavalesse Topical is a skincare gel that can be used in combination with the Cavalesse solution. The gel can be applied to the skin to help support natural immunity from the outside, whilst the oral solution works in partnership from the inside.
Helen Goldberg, marketing manager at Janssen Animal Health said: "Summer skin allergies, such as sweet itch, are frustrating conditions that can be difficult to treat. To help prevent the disease, horses are often fully blanketed while out at grass, given limited access to pasture or covered with insect repellents, while treatment has included antihistamines and corticosteroids which can have side-effects.
"Only available via veterinary wholesalers, the Cavalesse range of products will enable owners to protect their horses from the inside, whilst maintaining a healthy skin from the outside."
2ml of Cavalesse should be administered to horses and ponies weighing less than 500kg daily, while horses weighing more than 500kg should be given 3ml per day. Cavalesse Topical should be applied to the skin according to requirements.
For further information, please contact your Janssen Animal Health account manager or phone 01494 567555.
Janssen Animal Health is encouraging vets and nurses to think 'chicken' this spring.
According to the company, all the evidence suggests that there has been a massive increase in the number of people keeping a few chickens in their garden, resulting in a new breed of chicken owner who often has different expectations regarding healthcare, and views their birds as 'pets'.
Vet Nigel Underwood from Janssen Animal Health said: "It is very tempting for small animal practitioners to think that domestic poultry keepers are the preserve of large animal practices but it is very likely that many cat and dog owners will own chickens too and trust their vet to give them advice about the basic healthcare needs of all their pets."
This spring there is a big opportunity to make poultry owners aware of the need to worm their birds. The return of warmer weather can signal an increase in poultry worm numbers as the ambient temperature increases above 10 degrees centigrade and more worm eggs become infectious. Studies have shown that peak worm counts often coincide with peak chicken egg production. Unless chickens, turkeys and geese are de-wormed there is a risk that egg production could suffer, just when poultry keepers should be enjoying their best yields. Some may even notice smaller eggs and loss of shell and yolk colour. Birds may suffer weight loss, become anaemic or even die.
One study has shown that older birds are more likely to harbour worms and many domestic poultry keepers find themselves with an ageing flock because they allow their birds to live a full natural lifespan. Free range birds are also much more at risk of picking up parasitic worms because of increased exposure to the outdoors, more contact with wild birds and the opportunities to ingest intermediate hosts such as earthworms, beetles and snails.
Janssen Animal Health's Flubenvet® 60 gram pack is an in-feed treatment that, according to the company, is practical even for those with just a few hens in their garden. Flubenvet 60 gram contains enough wormer to treat around 20 chickens, with no egg withdrawal.
While worms are a year-round problem in poultry it is especially important to treat in the spring to tackle the increasing threat of worm infection. Thereafter, poultry owners will also get the best results if they continue to treat regularly in spring, summer and autumn, when new birds are acquired and before putting birds out to pasture. This helps to ensure that contamination of the chickens' environment with worm eggs is kept at a manageable level, reducing the risk of future infections.
Free client leaflets about worms affecting chickens, geese and turkeys are available by calling Janssen Animal Health on 01494 567555.
The British Veterinary Dental Association (BVDA) has signed a new agreement with Hill's Pet Nutrition which will provide support for the next three years.
The agreement comes after the previous period of sponsorship between the company and the BVDA reached the end of the three year term.
Lisa Milella, President, signed the agreement on behalf of the BVDA. She said: "Hill's has provided our organisation with invaluable support that will help us to continue to support the teaching needs of vets, undergraduates and nurses. We will also be able to ensure that dentistry is front of mind when thinking about the health and welfare of animals. Hill's has been a pleasure to work with over the last three years and I am very pleased to be renewing our agreement."
Adrian Pratt, Veterinary Affairs Manager at Hill's Pet Nutrition also welcomed the agreement, "Dentistry is an important source of revenue for practices and central to the wellbeing of pets. Both are priority areas where Hill's will be offering support, particularly during the current economic downturn. We are therefore very pleased to be able to confirm our association with the BVDA."
The agreement comes as the BVDA prepares to celebrate its 21st Birthday at BSAVA Congress in April. The satellite day event on the 1st April promises to be a 'must' for anyone interested in veterinary dentistry, with state of the art lectures that will illustrate how far the craft of dentistry has developed in the last 21 years.
The key note lecture, 'Magical MTA!*' will be delivered by Phil Thomson, Registrar at Birmingham Dental School, using a video linked operating microscope to illustrate how this gold standard endodontic treatment can be implemented. Additional lectures include oro-facial tumours, reconstructive surgery, radiotherapy and an active debate is promised on the topic of feline chronic gingivostomatitis. The meeting is open to members and non-members. Further details and registration are available by contacting Lisa Milella on telephone 01923 349690 or at lisa@milella.fsnet.co.uk.
*Mineral Trioxide Aggregate - MTA - a root canal repair material that allows natural healing and repair of dental tissues of otherwise unsalvageable teeth.
The RCVS issued a reminder today that there is just over a month left before the 1 April deadline for all veterinary practice premises from which medicines are to be supplied to be registered with the College.
Just over 4,500 premises have applied for registration since November 2008. This includes about 750 premises not previously listed with the College, demonstrating the usefulness of the process, which will enable the government to fulfil its obligations under European law to maintain and improve traceability of, and accountability for, veterinary medicines.
From 1 April it will be an offence for a veterinary surgeon to supply a veterinary medicinal product from any practice premises not registered with the RCVS. On conviction, those committing the offence may be liable to prosecution, which may include a fine or prison sentence. Veterinary surgeons convicted of criminal offences are also considered by the College's Preliminary Investigation Committee to decide whether the conviction would affect the individual's fitness to practise and should be referred to the Disciplinary Committee.
In addition to ensuring their practice premises are registered, veterinary surgeons also need to keep a record of other places where medicines are stored, so these can be considered during an inspection - such as vets' homes or cars, or perhaps a charity premises from which veterinary work is carried out and where medicines are stored. Such records will not be published, although some of those premises may need to be registered in their own right.
Practices accredited under the RCVS Practice Standards Scheme will be inspected by the RCVS; non-compliance with medicines standards will be dealt with under the rules of the Scheme. The Veterinary Medicines Directorate (VMD) will carry out inspections of other registered premises to ensure compliance with the Veterinary Medicines Regulations. Where non-compliance is noted, the VMD will take a proportionate enforcement approach ranging from issuing advice to, where appropriate, serving an improvement notice or seizing medicines.
VRCC the Essex-based veterinary referral specialists and centre for the treatment of cancer in dogs and cats has become the first in the UK to offer a canine melanoma vaccine.
The vaccine, previously only available in the U.S. where it has been granted a conditional license by the USDA, has been made available to VRCC's Head of Oncology Dr Susan North who fulfils the US Academic Credentials required.
According to VRCC, most oral tumours are not noticed early by owners, so many go undiagnosed and untreated until they are advanced and the dog has a poor chance of recovery.
Canine melanoma is an aggressive neoplasm treated with surgery and/or radiation therapy, which readily metastasises to the lymph nodes, liver, lungs and kidneys but is chemo-resistant. There is little evidence that chemotherapy improves survival time.
The canine melanoma vaccine develops effective immunotherapy in dogs that recognises and targets specific antigens on melanoma cells and may account for long-term tumour control and survival.
The vaccine is indicated for dogs with stage II or stage III oral melanoma for which local disease control has been achieved: negative local lymph nodes or positive lymph nodes that were surgically removed or irradiated.
The conditional license was granted based on the reasonable expectation that when used along with surgery and/or radiation therapy to treat the initial tumour the vaccine may help extend survival time and improve quality of life in dogs with canine oral melanoma.
US research concluded that canine patients with advanced disease have a median survival time of less than 5 months with standard therapies. In initial trials, dogs receiving the vaccination sequence had a median survival time of 389 days.
A canine transdermal device is especially matched to the vaccine for needle-free delivery and optimal distribution. Veterinary surgeons with a patient with oral melanoma should contact Dr Susan North at VRCC, www.vrcc.co.uk to discuss the case at an early stage, as initial treatment is important to ensure suitability for the vaccine.
Vetoquinol is advising vets and farmers to be on the lookout following the discovery of counterfeit Marbocyl on two farms in Northern Ireland.
The counterfeit product contains an unapproved source of Marbofloxacin in an untested formulation which presents an unknown risk to animal and human health if used.
Vetoquinol has informed the national authorities about this situation. It is illegal either to sell or supply the product or to knowingly buy and/or use it.
The withdrawal period of this counterfeit product is unknown. Should the product be used it could be detected in milk or after slaughter. Vetoquinol advises the veterinary community to be aware of the risk, to carefully check the product packaging before use and to continue to source the product from reputable suppliers.
Vetoquinol urges vets and farmers to take the following actions if you find this product on farm or are approached to purchase it:
Vetoquinol says vets can rest assured that it will do all that is necessary to remove this product from the market.
If you need further information or advice, do not hesitate to contact Vetoquinol on 0800 1698197.
Birds at two Bernard Matthews breeder sites in Suffolk and Norfolk have tested positive for avian influenza, though not the highly pathogenic H5 or H7 types.
A movement restriction has been put in place by DEFRA, but a cull has not so far been required. The BBC has the full story at: http://news.bbc.co.uk/1/hi/england/7912529.stm
Merial has announced that a recent change of licence means you can now administer the new generation NSAID, Previcox® for the relief of post operative pain associated with soft tissue and orthopaedic surgery in dogs.
Mark Riggs MRCVS, Veterinary Technical Advisor for Merial said: "Previcox (firocoxib) is now licensed for the relief of post operative pain. Oral PREVICOX can be administered starting 2 hours prior to surgery and has a rapid onset of action reaching peak plasma levels within 90 minutes. The palatable tablet can be given without food and is a realistic option which should be seriously considered when choosing pain relief for surgical patients.
"Containing the active ingredient firocoxib, Previcox is also highly COX-2 selective, being 380 times more selective for COX-2 than COX-1. As a result, it offers a highly desirable efficacy and safety profile which is particularly beneficial in cases which have gone through the additional stress of surgery.
"The recently published study by John P. Punke et al strengthens the evidence reinforcing the benefits offered by firocoxib. The research evaluated the in-vivo effects of firocoxib, meloxicam and tepoxalin in target tissues of dogs suffering with chronic osteoarthritis.
"Eight dogs were used in the cross-over study and each dog received each of the treatments (and a placebo) for seven days, with an appropriate wash out period in between. Firocoxib significantly reduced inflammatory mediators within blood and synovial fluid at all time points, whereas meloxicam only showed a significant reduction compared to baseline values at day four.
"With evidence demonstrating the speed of the anti-inflammatory effect of firocoxib, it may be time for vets to reconsider their post operative pain management. Previcox can be administered orally prior to surgery and can be given once daily for up to three days post operatively. For orthopaedic surgery this treatment schedule can be extended after the first 3 days upon judgement of the attending vet."
For further information please contact your local territory manager or call the Merial Customer Support Centre on 0845 601 4236.
Centaur has launched a new service on the MyCentaur website which allows for 24-hour ordering from any broadband enabled computer.
A secure practice shopping list with controlled staff access to ordering and management information enables practices to safely control any buying.
According to the company, a key feature of the website is that any orders placed on line by 9pm will be delivered the following day, which gives practices even greater flexibility on ordering times over any existing vet wholesaling ordering service. As well as greater convenience, a financial benefit in using this method of ordering is that all on-line orders attract an additional two per cent discount.
The Kennel Club has launched the Genetics Centre at the Animal Health Trust (AHT) to accelerate research into inherited canine disease.
It aims to create further diagnostic tests which, together with breeding advice, will improve the health and welfare of generations of dogs.
Because of the small gene pool in purebred dogs, inherited diseases resulting from single gene mutations are more likely to occur than in their cross bred cousins. This can lead to significant welfare issues. There are more than five million purebred dogs in the UK alone and many of these will benefit from the findings of the Genetics Centre.
Over the next five years, the centre aims to investigate 25 inherited diseases. It will develop, where possible, screening tests to determine affected and carrier dogs that can be performed with simple mouth swabs. In deciding which diseases to investigate, the joint Kennel Club and AHT team will look at their impact on the health and welfare of dogs, but also on the support of breeders and access to data and samples.
Dr Peter Webbon, Chief Executive of the AHT, said: "We're delighted to work in partnership with the Kennel Club on this important welfare issue. Our level of skill and expertise within this field is unparalleled and the new centre enables us to extend our current range of DNA tests.
"We hope, in time, this will equip breeders with essential information so they can plan successful breeding strategies to avoid the birth of affected dogs, and ultimately, to eliminate disease from breeds at risk."
Dr. Cathryn Mellersh and Dr. Sarah Blott, two of the AHT's genetics experts, will lead the Centre. Both have been fundamental in identifying defective genes and developing screening tests which identify a dog's genetic status and minimise the risk of producing affected puppies.
The Centre will also introduce new approaches in dog breeding. One major advance will be estimated breeding values (EBVs). These will enable whole dog populations to be evaluated for inherited disease - even if individuals haven't been scanned or DNA tested themselves.
Caroline Kisko, Kennel Club spokesperson, said: "The Kennel Club is pleased to support research which improves the health and happiness of dogs. Working in partnership with the Animal Health Trust means we can start to tackle the problem of inherited disease much quicker.
"We have already made significant investment in this area, and are now delighted to step up the scope of this research. It is a very real possibility that through this Centre we will be able to eradicate certain inherited diseases in some dogs."
Dr Ed Hall, President of BSAVA, said: "Inherited disease is one part of a complex issue involved with breeding pedigree dogs.
"I personally welcome any efforts to improve our current understanding of the area and trust that the Kennel Club Genetics Centre will make massive progress in the next five years in order to enable owners to make informed breeding decisions and, in time, to reduce the effect of inherited disease."
Details of the new charges are found on the in-flight safety card ...
A new solution to a problem vets encounter when using a conventional, usually human health, laryngoscope on small animals has been devised by Prof Paul Flecknell of Newcastle University in collaboration with Alstoe Animal Health.
Called the FlecknellTM , this small animal laryngoscope uses a specially-designed, streamline, slimmed-down blade to maximise the view of the larynx, particularly with rabbits in mind. According to Alstoe, the new design also greatly reduces the risk of damage to an animal's gums or pharynx as the blade is inserted.
Prof Flecknell, MA, VetMB, PhD, DECLAM, DLAS, DECVA, (Hon) DACLAM, (Hon) FRCVS said: "Many practitioners have complained that existing blades were not suitable for small animal work and they were not happy with using a blind technique, as they really wanted to see the larynx and intubate under direct vision.
"So, over several years of development, we worked through prototypes and changed both the shape of the blade and the type and position of the light source. As well as trying the prototypes ourselves, Alstoe carried out trial work with vets in practice, resulting in this final design, which we think is much easier to use than other blades currently on the market.
"We hope this will encourage vets to intubate more rabbits, since this will enable them to be anaesthetised more safely. One of the commonest problems seen is depressed respiration progressing to apnoea, and trying to assist ventilation using a face mask often results only in inflation of the stomach, making matters worse. Once an endotracheal tube is in place, ventilation can be assisted easily if needed."
Niall McFerran from Alstoe said: "The Flecknell still requires some practice to master the use of the blade, and so we have produced a DVD and leaflet demonstrating its use. The Flecknell blade can be used to intubate a range of small animals, cats, dogs, as well as the original target rabbits.
"We were delighted to have worked with such an eminent specialist as Prof Flecknell and his team on a genuinely vet-led need to help with animal welfare. And this is just the start, as 2009 is going to be the busiest ever year for new product introductions for Alstoe Animal Health."
For more information, contact Alstoe Animal Health www.alstoe.co.uk
Hill's Pet Nutrition has decided to make its library of symposia proceedings freely available to all vets. It's part of Hill's drive to support vets with training during tough times.
The library, which has been built up over 13 years, is made up of the proceedings and supporting articles from lectures covering topics as diverse as inflammatory bowel disease in the feline and nutrigenomics.
Adrian Pratt, Veterinary Affairs Manager, said: "These proceedings contain definitive texts on conditions that are commonly seen in practice, described at an advanced level but in an easy to assimilate format. We do have a number of proceedings still in stock and I would much rather see them being used and all that valuable knowledge put into practice."
Anyone in practice with an interest in a particular area can apply to receive a copy of their preferred symposium.
According to Hill's, these booklets are excellent tools for those seeking to fill their CPD requirement through self-directed learning and provide advanced material that can be difficult to access elsewhere (note that undocumented self learning can only account for up to 10 hours on the RCVS record card).
The service is completely free of charge and orders can be placed by calling 01923 814454. As copies of some seminars are available only in limited numbers, applicants are asked to select only those proceedings in which they have a genuine area of interest. Only one copy of each symposium proceeding will be supplied to each individual, although multiple topics can be selected.
Symposia Proceedings TitlesHill's European Symposium on Chronic Renal Disease 2004Hill's European Speaker Tour on Canine Joint Health- Advances in clinical management and Nutrigenomics 2005Hill's European Symposium on Advances in Feline Medicine 2006Hill's Symposium on Dermatology Palm Springs 2006 Hill's European Symposium on 'Moving on with mobility' 2007
Those who wish to supplement their learning further may wish to visit The Vet Nutrition Academy which also provides a number of free and subsidised courses to members of the veterinary healthcare team. Registration is free at www.myhillspet/vna. To complete registration the practice U number will be required and this is available by contacting Jane Quail at Hill's on 01923 814454.
Petplan has announced the finalists for the 2009 Veterinary Awards.
The company says it was inundated with more than 2300 nominations this year and that the public response was 'astonishing', with tales ranging from midnight rescues to simple acts of kindness and this year was no exception.
The finalists for each of the categories are as follows:
Vet of the YearJamie Rushton, Village Vet Hampstead, LondonBen Jones, Ben Jones Veterinary Surgery, Chester, FlintshireMatthew Fry, Quarrington Veterinary Surgery, Sleaford, Lincolnshire
Vet Nurse of the YearCharlotte Maude, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldKaren McQuaid, The Old Golfhouse Veterinary Group, Watton, NorfolkRachel Smith, 608 Veterinary Group, Solihull, West Midlands
Vet Receptionist of the YearYasmin Morowa, Melton Veterinary Surgery, Woodbridge, SuffolkJackie Crampton, Companion Care Veterinary Surgery Chesterfield, Markham, ChesterfieldSara Abbott, Pet Doctors, East Horsley, Surrey
Vet Practice of the YearAshfield House Veterinary Hospital Limited, Long Eaton, NottinghamshireCarrick Veterinary Group CVS (UK) Ltd, Newbold, ChesterfieldSt Clair Veterinary Group, Kirkcaldy, Fife
Simon Wheeler, Petplan's Head of Marketing said he was thrilled by the record number of nominations received:
"This year we are celebrating the tenth anniversary of the Veterinary Awards which were launched so pet owners could thank their practice for the tireless and wonderful work they carry out. We are delighted that the awards, which we often hear referred to as the 'Vet Oscars', are still going strong. This year we have received over 2300 nominations and the quality and standard really challenged the skills of our esteemed judging panel. We would like to wish those short listed every success on the night."
All finalists will be invited to a 'glittering' awards ceremony that will take place on 2nd April at the Burlington Hotel in Birmingham where the winners will be announced.
Fort Dodge Animal Health has announced that the European Medicines Agency (EMEA) has approved a new label claim for ProMeris Duo® for dogs. The new claim extends protection offered by ProMeris Duo to include "treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs".
Accoding to the company, dealing with demodectic mange on a dog has in the past been time-consuming for the pet owner and sometimes required vets to use a product off-label. Despite available measures, some dogs fail to respond to treatment and even require euthanasia due to the severity of the condition.
Rami Cobb, BVSc (Hons), MACVSc, Senior Vice President of Pharmaceutical Research and Development at Fort Dodge Animal Health said: "With the addition of the demodectic mange claim to the ProMeris Duo label, vets have the option of using the recognized efficacy of amitraz in a convenient spot-on formulation to treat and control this condition.
"When we conducted field studies for the label claim, the before and after pictures of the dogs treated with ProMeris Duo were remarkable. Visible improvements in the dog's condition were seen following the first treatment and in most cases, demodex mites could not be found after just a few months."
ProMeris Duo was evaluated for efficacy against demodectic mange mites in naturally infected dogs. Study results indicated dogs treated monthly with ProMeris Duo showed significant reduction in mite numbers and improvement in clinical signs after three months.
ProMeris Duo is now licensed for the following indications: For the treatment and prevention of infestations by fleas (Ctenocephalides canis and C. felis), as well as ticks (Ixodes ricinus, Ixodes hexagonus, Rhipicephalus sanguineus, Dermacentor reticulatus and Dermacentor variabilis), and treatment of demodicosis (caused by Demodex spp.) and lice (Trichodectes canis) in dogs. The veterinary medicinal product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
Genitrix has announced that HY-50 Vet®, a sodium hyaluronate treatment for equine joints, has now been authorised for intravenous (IV) use.
Available until now for intra-articular (IA) use only, the company says HY-50 delivers the highest concentration of sodium hyaluronate on the market for the treatment of non-infectious joint inflammation and the enhancement of joint function.
Genitrix also says that, as IV application requires less specialist preparation than IA, HY-50 is now a practical solution for mixed practices with a smaller equine case load. Injected intravenously, the product will also benefit horses with multiple joint injuries.
HY-50 is presented in a 3 ml pre-loaded syringe, delivering 50 mg of sodium hyaluronate. It costs £55.50.
Rob Watkins, Marketing Director of Genitrix, said: "The efficacy of sodium hyaluronate is well established and we're delighted to be able to offer the IV route of administration. We know it will meet a real need in the market for a lameness treatment which is proven and simple to administer."
"Perhaps most importantly, in these financially difficult times, the high concentration of the product makes it a cost-effective approach compared with competitive products. We believe it will offer an affordable treatment option for owners who are anxious to treat their horses but may be discouraged by the high cost of many treatments."
For further information, see http://www.genitrix.co.uk/ or ring 01403 786345.
Siemens will be showcasing its range of technology for veterinary care, from advanced ultrasound, CT and MRI systems to haematological and immunological diagnostics at BSAVA Congress.
The company says MRI and CT are starting to become more influential in the veterinary field. MRI provides a reliable veterinary imaging method when traditional procedures such as X-ray and ultrasound are not able to convey the detail needed. They display small changes in bone and soft tissue and can be complemented with special adjustments such as mini coils for dog and cat paws to make them suitable for application with animals. This allows vets to diagnose more accurately and treat specific complaints. The images produced by MRI systems can be used for tumour diagnosis, nervous complaints or orthopaedic problems as well as intestinal, respiratory or cardiovascular disorders.
Siemens will also be presenting its in vitro range of solutions and assays in chemistry, haematology and immunology.
This will include the IMMULITE® range, a blood testing platform which the company says has an unrivalled immunoassay portfolio, allowing the rapid diagnosis of a broad spectrum of small animal conditions.
Information on the ADVIA® 2120i Haematology System with specific animal software and Dimension® Xpand® Plus integrated chemistry and immunoassay system will also be available.
Product literature and in-depth discussions with Siemens specialists will be available from the stand during the event.
The Royal College of Veterinary Surgeons Trust is looking for a vet with a particular interest in veterinary education, professional development and research, to be a new trustee.
The RCVS Trust is an independent small charity that provides two key services to the veterinary profession to further education and animal welfare: an educational grants programme and a Library and Information Service. It is seeking a trustee who can bring new contacts and ideas relevant to the work of the Trust.
The Trust is also seeking further 'lay' trustees with experience of library services, fundraising and grant-making.
The current Board members have a wide range of experience from academia, government, animal health and small and large animal practice, and veterinary nursing. However, there is room for some new Trustees to join and bring the Board up to full strength.
Stephen Ware, Chairman of the Board of Trustees, said: "The Trust has an important role in supporting practising vets, veterinary nurses, researchers, students and academics through its grants programmes and library and information resources."
"We are looking for a veterinary surgeon who is actively involved in the wider profession through networks and specialist interest groups, and who is willing to promote the work of the Trust, for example, at veterinary congresses. Given the nature of the Trust's work, the new trustee should also have experience of postgraduate education or research.
"We need someone who has the energy and experience to get things done - and who can work with other trustees in a collegiate style."
Trustees serve an initial three-year term, spending around six days a year at meetings in London and conferences. Reasonable expenses are reimbursed. Experience of charity governance and finance is not necessary as training and support will be given.
Those interested in the role can contact Cherry Bushell, Director of the RCVS Trust, for an informal discussion and an application form. The closing date for applications is 30 April.
CVS Group has announced record half-year pre-tax profits of £1.9m, indicating the robustness of the veterinary sector in harsh economic conditions.
Like-for-like sales were up 2.3% in the first half. However, according to a report in the Daily Telegraph, the company has said revenue from sales of inessentials like preventative flea control may yet fall.
Mike Martin, an RCVS Specialist in Veterinary Cardiology, has launched a new reference library of cardiology echo scans on VetSurgeon.org.
The movies show cardiac scans performed on normal dogs, and on cats and dogs with a variety of different conditions, both acquired and congenital.
Mike said: "I hope these movies will be a really helpful reference for colleagues who have an interest in cardiology. They provide so much more information than can be gleaned from a still image in a textbook, now that online video quality has improved so much."
Mike's gallery is an excellent example of the way in which a social networking website like VetSurgeon allows its members to share information and collaborate. Other referral practitioners interested in having their own gallery in which to share videos or images with colleagues in the profession should contact the site editor, Arlo Guthrie for further details.
Click here to visit Mike Martin's Cardiology Gallery
Plans for the introduction of a disciplinary mechanism for Registered Veterinary Nurses (RVNs) have been agreed by the RCVS Veterinary Nurses Council.
RVNs agree to account for their professional conduct and keep their skills and knowledge up to date: over 70% of eligible veterinary nurses have now joined the non-statutory Register.
The Veterinary Nurses Council agreed to a period of nearly three years between the opening of the Register and the College putting in place a disciplinary mechanism. This was to give RVNs time to get used to their new rights and responsibilities. Plans are now in place to introduce a disciplinary system from September 2010.
Charges could be brought against a veterinary nurse if found guilty of fraudulent registration, criminal convictions which render him or her unfit to practise as a veterinary nurse, or allegations of disgraceful professional conduct.
The sanctions would be the same as for veterinary surgeons, ie to remove a nurse's name from the Register (with the nurse eligible to apply for restoration after 10 months), or to suspend the nurse, with his or her name returning to the Register immediately after the period of suspension. A veterinary nurse would not be able to carry out Schedule 3 tasks while removed from the Register.
Complaints would initially be dealt with by the Veterinary Nurses Preliminary Investigation Committee (VN PIC), which will assess whether the complaints should be taken to the hearing stage. Three RVNs will sit on this committee. They will be joined by three members of the veterinary PIC, including either the RCVS President, or one of the Vice-Presidents, and one Lay Observer.
Meanwhile three RVNs will join existing members of the RCVS Disciplinary Committee (DC) to form a VN DC, to adjudicate on charges against a veterinary nurse. These individuals will not currently sit on VN Council. If the case were against a VN, the sitting panel would include at least one veterinary nurse, one veterinary surgeon and a lay person acting as chairman. A legal assessor would also sit with the Committee to offer advice.
If a case were to concern both a veterinary surgeon and a veterinary nurse, the preliminary investigation would be carried out in tandem but with separate disciplinary hearings.
Applications are invited for RVNs to sit on the new VN Preliminary Investigation or Disciplinary Committees. Anyone who would like further information should contact Lesley Evans, Manager, Executive Office (l.evans@rcvs.org.uk or 020 7222 2001) by 31 May 2009.